Defining the immunogenicity of embryonic stem cell-derived dopaminergic progenitors as a cell replacement therapy for Parkinson's disease (2019)

First Author: Qarin Shamma
Attributed to:  The Pluripotent Stem Cells and Engineered Cell (PSEC) Hub funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract